The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
This case also might have an impact on future cases brought against drug companies…and brings the FDA into a touch situation as well. No 2 cases are the same and every detail of each case has to be evaluated. On the other hand it calls for the utmost scrutiny by the FDA to grant approvals...